Trial Profile
Elixir Medical's second first-in-man study of a myolimus-eluting coronary stent with a biodegradable polymer coating.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 May 2012
Price :
$35
*
At a glance
- Drugs Myolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Adverse reactions; Therapeutic Use
- 18 May 2012 New trial record